Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates

Abstract excerpt

Complete response (CR) rates reported for cytotoxic chemotherapy for late-stage cancer patients are generally low, with few exceptions, regardless of the solid cancer type or drug regimen. We investigated CR rates reported in the literature for clinical trials using chemotherapy alone, across a wide range of tumour types and chemotherapeutic regimens, to determine an overall CR rate for late-stage cancers. A total...

Topics

Open a Topic to create a Post that cites this publication.

• Alkyl and Aryl Transferases
• Clinical Trials as Topic
• Endothelial Growth Factors
• Genetic Therapy
• Lymphokines
• Telomerase
• Vascular Endothelial Growth Factor A
• Vascular Endothelial Growth Factors

Identifiers and source

Literature Corpus work

30a2fa1c-f24e-55a1-83d7-a83c2b890c1c

DOI

10.12688/f1000research.6760.1